Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Ranging Study of Sublingual Immunotherapy (SLIT) in Adults Sensitized to the Standardized Allergenic Extract, Cat Hair (Felis Domesticus).

Next Previous
Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Ranging Study of Sublingual Immunotherapy (SLIT) in Adults Sensitized to the Standardized Allergenic Extract, Cat Hair (Felis Domesticus).

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jun 2014

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cat allergy immunotherapy (Primary)
  • Indications Allergic rhinitis; Hypersensitivity
  • Focus Therapeutic Use
  • Sponsors Antigen Laboratories

Most Recent Events

  • 25 Nov 2009 According to a Planet Biopharmacueticals media release, all three treatment groups, low dose, high dose and placebo, improved symptoms significantly compared to baseline. Further phase II trials are required prior to entering phase III.
  • 16 Oct 2009 Actual patient number (167) added, actual initiation date (Oct 2008) added as reported by ClinicalTrials.gov.
  • 16 Oct 2009 Actual end date (June 2009) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top